ENDRA Life Sciences Inc. (NDRA) Earnings History
Net Loss12 years of earnings data (2014–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
ENDRA Life Sciences Inc. (NDRA) Earnings Overview
As of June 28, 2026, ENDRA Life Sciences Inc. (NDRA) reported trailing twelve-month net income of -$7M, reflecting +12.9% year-over-year growth. The company earned $-6.09 per diluted share over the past four quarters.
Looking at the long-term picture, NDRA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2014.
ENDRA Life Sciences Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SENS (-$87M net income, -196.0% margin), LNTH ($279M net income, 15.2% margin), IMVT (-$506M net income), NDRA has comparable earnings metrics. Compare NDRA vs SENS →
NDRA Earnings vs Peers
Earnings metrics vs comparable public companies
NDRA Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$7M | +38.9% | -$6M | $-8.93 | - | - |
| 2024 | -$12M | -14.4% | -$11M | $-10.25 | - | - |
| 2023 | -$10M | +23.7% | -$11M | $-5.89 | - | - |
| 2022 | -$13M | -17.3% | -$13M | $-6.84 | - | - |
| 2021 | -$11M | +4.2% | -$11M | $-5.47 | - | - |
| 2020 | -$12M | +11.9% | -$12M | $-12.47 | - | - |
| 2019 | -$13M | -35.8% | -$11M | $-41.48 | - | - |
| 2018 | -$10M | -82.2% | -$9M | $-43.49 | -158669.6% | -146080.5% |
| 2017 | -$5M | -93.7% | -$5M | $-27.47 | -1529.2% | -1315.6% |
| 2016 | -$3M | -21.8% | -$2M | $-14.21 | -538.3% | -347.5% |
| 2015 | -$2M | -4.5% | -$2M | $-11.67 | -161.6% | -111.2% |
| 2014 | -$2M | - | -$2M | $-71.20 | -389.9% | -272.8% |
Download Data
Export NDRA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NDRA — Frequently Asked Questions
Quick answers to the most common questions about buying NDRA stock.
What is NDRA earnings per share (EPS)?
NDRA trailing twelve-month (TTM) diluted EPS is $-6.09, reflecting +12.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2014 to 2025 is available in the table on this page.
What is ENDRA Life Sciences Inc.'s net income?
ENDRA Life Sciences Inc. (NDRA) trailing twelve-month net income is $-7M as of 2025. Earnings grew +12.9% year-over-year.
Is NDRA profitable?
NDRA is not currently profitable on a TTM basis, reporting a net loss of $-7M. Net margin is N/A. Investors should monitor for a return to profitability.
What is NDRA's earnings growth rate?
NDRA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.
What are NDRA's profit margins?
ENDRA Life Sciences Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -291.6%.
Is NDRA growing earnings?
NDRA is growing earnings steadily. YoY EPS growth of +12.9% is consistent with the 5-year CAGR of N/A. TTM net income is $-7M.
What was NDRA's best earnings year?
ENDRA Life Sciences Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2014. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.
What were NDRA's earnings last quarter?
NDRA's most recent reported quarter was Q1 2026. Net income was $-1M with diluted EPS of $-1.09. For a full breakdown of all quarters, see the quarterly earnings table on this page.